Previous 10 | Next 10 |
2023-08-04 06:00:11 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Many investors, including a significant number of very wealthy individuals and institutions, are becoming enthralled with AI stocks . According to Goldman Sachs (NYSE: ...
2023-08-03 20:17:51 ET Shares of Schrödinger (NASDAQ: SDGR) were down more than 22% on Thursday after the healthcare computational platform services company released second-quarter earnings. The healthcare stock is still up more than 108% so far this year. Schrödin...
2023-08-03 10:16:24 ET Gainers: Bluejay Diagnostics ( BJDX ) +74% . Adamis Pharmaceuticals ( ADMP ) +59% . T2 Biosystems ( TTOO ) +47% . Community Health Systems ( CYH ) +18% . Cyclo Therapeutics ( CYTH ) +17% . Losers:...
2023-08-03 09:05:43 ET Aravive ( ARAV ) -58% announces top-line results from phase 3 AXLerate-OC study of batiraxcept in patinum-resistant ovarian cancer. Vicarious Surgical ( RBOT ) -41% on pricing $45M offering . DXC Technology Company ( DXC ) -24% ...
2023-08-03 05:34:58 ET Stock futures fell in the early hours of Thursday as risk-off sentiment continues following Fitch's downgrading of the United States' credit rating and hot jobs data. Here are some of Thursday's biggest stock movers in premarket trading: Biggest stock gainers ...
2023-08-02 20:35:25 ET Schrödinger, Inc. (SDGR) Q2 2023 Earnings Conference Call August 2, 2023, 4:30 pm ET Company Participants Jaren Madden - SVP, IR & Corporate Affairs Ramy Farid - CEO Geoff Porges - CFO Karen Akinsanya - President R&D, Thera...
2023-08-02 16:02:56 ET Schrödinger press release ( NASDAQ: SDGR ): Q2 GAAP EPS of $0.06 beats by $0.53 . Revenue of $35.2M (-8.6% Y/Y) misses by $3.08M . 2023 Financial Outlook As of August 2, 2023, Schrödinger provided the following updated exp...
Announces IND Clearance for CDC7 Inhibitor SGR-2921, Continued Progress for MALT1 Inhibitor SGR-1505 Delivers Second Quarter Total Revenue of $35.2 Million Raises 2023 Software Revenue Guidance and Reduces Drug Discovery Guidance Schrödinger, Inc. (Nasdaq: SDGR), wh...
2023-07-26 18:00:35 ET Summary Schrödinger excels in drug and materials discovery through its computational platform, with consistent revenue growth and collaborations. Several promising drug discovery programs are underway, bolstered by Schrödinger's computational platf...
Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its second quarter 2023 financial results on Wednesday, August 2, 2023, after the financial markets close. The company will host a conference ...
News, Short Squeeze, Breakout and More Instantly...
Initiative initially funded by $10 million grant from the Bill & Melinda Gates Foundation Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that it is embarking on ...
Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its second quarter 2024 financial results on Wednesday, July 31, 2024, after the financial markets close. The company will host a conference c...
2024-07-14 09:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...